Q BIOMED INC. ADVISOR AND MANNIN RESEARCH INC CSO DR SUSAN QUAGGIN ELEQUENTLY DISCUSSES GLAUCOMA AND MAN-01 WITH EYE ON VISION RADIO

Media Alert – Radio and Podcast Interview with Eye on Vision WYPL-FM 89.3 NEW YORK, July 14 2016 — Q BioMed Inc. (OTCQB: QBIO), partner Mannin Research Inc. CSO Dr. Susan Quaggin discusses glaucoma, treatment options, and her novel findings on the relationship between Tie2/TEK signaling, Schelmm’s Canal and glaucoma with Eye on Vision. In […]

Read More

NEW SNN Interview with Q BioMed Inc. CEO Mr. Denis Corin at the Marcum Microcap Conference June 2016

In this video interview, Mr. Corin and SNN host Robert Kraft discuss the following topics: Overview of Q BioMed Inc. Update since our last interview (Click here) Discusses recent news and catalysts New potential FDA approved Drug License Deal What differentiates QBIO from the competition Communicating the stories of projects under development Near-term goals and […]

Read More

Q BIOMED INC. REPORTS ON CURRENT AND NEW POTENTIAL ASSETS

New Near Term Revenue Asset Deal Pending and MAN-01 Drug Candidate Optimization and Selection Progressing on Schedule NEW YORK, June 1, 2016 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to report on new potential asset license/acquisition and an update on Man 01 development. We are pleased to announce that we […]

Read More

MANNIN RESEARCH TO PARTICIPATE AT ARVO 2016 MEETING

New York,  April 4,2016- Q BioMed Inc. (QBIO), a biotechnology acceleration company announces that its technology partner Mannin Research Inc. will be attending the Association for Research in Vision and Ophthalmology (ARVO), which takes place from May 1-5, 2016 in Seattle Washington. Mannin Research executives will be meeting with its vendors and research partners. The […]

Read More

Q BioMed Inc. To Present at the Global Chinese Financial Forum on April 30, 2016

Toronto, ON Conference Expects to attract over 200 participants New York, NY– (April 26, 2016)– Q BioMed Inc. (OTCQB: QBIO) a biotechnology acceleration company, today announced that the company will present at the Global Chinese Financial Forum (GCFF). The GCFF is the most prominent series of bi-lingual financial functions in both North America and China. […]

Read More

MANNIN RESEARCH TO PRESENT GLAUCOMA THERAPEUTICS TREATMENT AT MEDCITY INVEST CHICAGO APRIL 12 -13 2016

Management to Present Lead drug candidate to Industry and Venture Finance Executives NEW YORK, April 12, 2016 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce that its  license technology partner,  Mannin Research, will present at  MATTER Midwest University HealthTech Showcase on April 12 – 13th, 2016. Mannin Research will […]

Read More

Media Alert – Q BioMed Inc Featured in April issue of PharmaVOICE Magazine

Getting Past the “Pharma Bro”; How Smaller Biotechs Continue to Strive for the Well-Being of Patients   New York,  April 5 ,2016  – Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company reports the Company’s CEO  was featured in  an interview in the April issue of PharmaVOICE magazine. PharmaVOICE magazine, reaching more  than 41,000 BPA-qualified life-sciences […]

Read More

StockNewsNow.com Publishes New SNNLive Video Interview With Q BioMed Inc.

LOS ANGELES, CA–(Marketwired – March 24, 2016) –  StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Denis Corin, Chairman and CEO of Q BioMed Inc. (OTCQB: QBIO), a biomedical acceleration and development company, according to the Company’s website (see here: www.QBioMed.com). The video interview was recorded on Monday, February 22nd, […]

Read More
Social media & sharing icons powered by UltimatelySocial